| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10303927 | Psychiatry Research | 2014 | 7 Pages | 
Abstract
												Cost-prohibitive factors currently prevent a warranted integration of neuropsychological screenings into routine psychiatric evaluations, as a standard of care. To overcome this challenge, the current study examined the psychometric properties of a new computerized measure-the CNS Screen. One hundred and twenty six psychiatric inpatients completed the CNS Screen, the Montreal Cognitive Assessment (MoCA), and the Quick Inventory of Depressive Symptomatology-Self Rated (QIDS-SR16) on the day of hospital discharge. Statistical analysis established convergent validity with a moderate correlation between the self-administered CNS Screen and the clinician-administered MoCA (r=0.64). Discriminant validity was implicated by a non-significant correlation with the QIDS-SR16. Concurrent validity was supported by a moderate, negative correlation with patients' age (r=â0.62). In addition, consistent with previous findings, patients with psychotic disorders exhibited significantly poorer performance on the CNS Screen than patients with a mood disorder. Similarly, patients with a formal disability status scored significantly lower than other patients. The CNS Screen was well tolerated by all patients. With further development, this type of measure may provide a cost-effective approach to expanding neuropsychological screenings on inpatient psychiatric units.
											Keywords
												
											Related Topics
												
													Life Sciences
													Neuroscience
													Biological Psychiatry
												
											Authors
												Boaz Levy, Selda Celen-Demirtas, Tinatin Surguladze, Sara Eranio, James Ellison, 
											